• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchFreeline Therapeutics Holdings
    Picture of Freeline Therapeutics Holdings logo

    FRLN — Freeline Therapeutics Holdings Share News

    $6.480.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapMomentum Trap
    • Market Cap
      $28.24m
    • Enterprise Value
      -$1.21m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • FRLN Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    FRLN Dividends
    • REG - Syncona Limited - Freeline presents data in Fabry disease

      08/02/2022 13:05Announcement
    • REG - Syncona Limited - Freeline reports 2022 priorities and guidance

      14/12/2021 08:00Announcement
    • REG - Syncona Limited - Freeline presents data in haemophilia B

      13/12/2021 15:05Announcement
    • REG - Syncona Limited - Freeline reports new data and 3rd Quarter Results

      10/11/2021 08:05Announcement
    • REG - Syncona Limited - Freeline Reports Executive Change and Q2 Results

      16/08/2021 13:10Announcement
    • REG - Syncona Limited - Freeline reports Q1 results

      18/05/2021 08:05Announcement

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.